Physician profile
Kevin D Epple
NPI 1699759118
$312.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2023: $155 · 2024: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $67.98 | 2021-2024 | Rybelsus, Ozempic |
| Neos Therapeutics, LP | $57.61 | 2023 | Adzenys Xr-Odt |
| Lilly USA, LLC | $45.09 | 2021-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $21.25 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.12 | 2023 | Rexulti |
| Merck Sharp & Dohme LLC | $20.01 | 2021 | |
| Abbvie INC. | $17.29 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $16.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.71 | 2021 | |
| Exact Sciences Corporation | $14.56 | 2023 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $14.31 | 2023 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Epple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.